Moreover, GSTO1 has been shown to be involved in the conversion of protoporphyrin IX into heme in cells, in that way participating in the antitumor action of photodynamic therapy, while high levels of GSTO1 expression have been found to be associated with the increased sensitivity to this type of treatment in different ovarian cancer cell lines [30]. The gene discussed is GSTO1; the disease is ovarian cancer.